1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-glaucoma Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Miosis Drugs
1.2.3 Beta-blocker
1.2.4 Adrenergic Agonists
1.2.5 Carbonic Anhydrase Inhibitor
1.2.6 Prostaglandin Derivative Agent
1.2.7 Penetrates
1.3 Market by Application
1.3.1 Global Anti-glaucoma Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacy
1.3.3 Drugstore
1.3.4 Online Sales
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Anti-glaucoma Drug Market Perspective (2016-2027)
2.2 Anti-glaucoma Drug Growth Trends by Regions
2.2.1 Anti-glaucoma Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anti-glaucoma Drug Historic Market Share by Regions (2016-2021)
2.2.3 Anti-glaucoma Drug Forecasted Market Size by Regions (2022-2027)
2.3 Anti-glaucoma Drug Industry Dynamic
2.3.1 Anti-glaucoma Drug Market Trends
2.3.2 Anti-glaucoma Drug Market Drivers
2.3.3 Anti-glaucoma Drug Market Challenges
2.3.4 Anti-glaucoma Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-glaucoma Drug Players by Revenue
3.1.1 Global Top Anti-glaucoma Drug Players by Revenue (2016-2021)
3.1.2 Global Anti-glaucoma Drug Revenue Market Share by Players (2016-2021)
3.2 Global Anti-glaucoma Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anti-glaucoma Drug Revenue
3.4 Global Anti-glaucoma Drug Market Concentration Ratio
3.4.1 Global Anti-glaucoma Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-glaucoma Drug Revenue in 2020
3.5 Anti-glaucoma Drug Key Players Head office and Area Served
3.6 Key Players Anti-glaucoma Drug Product Solution and Service
3.7 Date of Enter into Anti-glaucoma Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-glaucoma Drug Breakdown Data by Type
4.1 Global Anti-glaucoma Drug Historic Market Size by Type (2016-2021)
4.2 Global Anti-glaucoma Drug Forecasted Market Size by Type (2022-2027)
5 Anti-glaucoma Drug Breakdown Data by Application
5.1 Global Anti-glaucoma Drug Historic Market Size by Application (2016-2021)
5.2 Global Anti-glaucoma Drug Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Anti-glaucoma Drug Market Size (2016-2027)
6.2 North America Anti-glaucoma Drug Market Size by Type
6.2.1 North America Anti-glaucoma Drug Market Size by Type (2016-2021)
6.2.2 North America Anti-glaucoma Drug Market Size by Type (2022-2027)
6.2.3 North America Anti-glaucoma Drug Market Size by Type (2016-2027)
6.3 North America Anti-glaucoma Drug Market Size by Application
6.3.1 North America Anti-glaucoma Drug Market Size by Application (2016-2021)
6.3.2 North America Anti-glaucoma Drug Market Size by Application (2022-2027)
6.3.3 North America Anti-glaucoma Drug Market Size by Application (2016-2027)
6.4 North America Anti-glaucoma Drug Market Size by Country
6.4.1 North America Anti-glaucoma Drug Market Size by Country (2016-2021)
6.4.2 North America Anti-glaucoma Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Anti-glaucoma Drug Market Size (2016-2027)
7.2 Europe Anti-glaucoma Drug Market Size by Type
7.2.1 Europe Anti-glaucoma Drug Market Size by Type (2016-2021)
7.2.2 Europe Anti-glaucoma Drug Market Size by Type (2022-2027)
7.2.3 Europe Anti-glaucoma Drug Market Size by Type (2016-2027)
7.3 Europe Anti-glaucoma Drug Market Size by Application
7.3.1 Europe Anti-glaucoma Drug Market Size by Application (2016-2021)
7.3.2 Europe Anti-glaucoma Drug Market Size by Application (2022-2027)
7.3.3 Europe Anti-glaucoma Drug Market Size by Application (2016-2027)
7.4 Europe Anti-glaucoma Drug Market Size by Country
7.4.1 Europe Anti-glaucoma Drug Market Size by Country (2016-2021)
7.4.2 Europe Anti-glaucoma Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Anti-glaucoma Drug Market Size (2016-2027)
8.2 Asia-Pacific Anti-glaucoma Drug Market Size by Type
8.2.1 Asia-Pacific Anti-glaucoma Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anti-glaucoma Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anti-glaucoma Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Anti-glaucoma Drug Market Size by Application
8.3.1 Asia-Pacific Anti-glaucoma Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anti-glaucoma Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anti-glaucoma Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Anti-glaucoma Drug Market Size by Region
8.4.1 Asia-Pacific Anti-glaucoma Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anti-glaucoma Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Anti-glaucoma Drug Market Size (2016-2027)
9.2 Latin America Anti-glaucoma Drug Market Size by Type
9.2.1 Latin America Anti-glaucoma Drug Market Size by Type (2016-2021)
9.2.2 Latin America Anti-glaucoma Drug Market Size by Type (2022-2027)
9.2.3 Latin America Anti-glaucoma Drug Market Size by Type (2016-2027)
9.3 Latin America Anti-glaucoma Drug Market Size by Application
9.3.1 Latin America Anti-glaucoma Drug Market Size by Application (2016-2021)
9.3.2 Latin America Anti-glaucoma Drug Market Size by Application (2022-2027)
9.3.3 Latin America Anti-glaucoma Drug Market Size by Application (2016-2027)
9.4 Latin America Anti-glaucoma Drug Market Size by Country
9.4.1 Latin America Anti-glaucoma Drug Market Size by Country (2016-2021)
9.4.2 Latin America Anti-glaucoma Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-glaucoma Drug Market Size (2016-2027)
10.2 Middle East & Africa Anti-glaucoma Drug Market Size by Type
10.2.1 Middle East & Africa Anti-glaucoma Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anti-glaucoma Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anti-glaucoma Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Anti-glaucoma Drug Market Size by Application
10.3.1 Middle East & Africa Anti-glaucoma Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anti-glaucoma Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anti-glaucoma Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Anti-glaucoma Drug Market Size by Country
10.4.1 Middle East & Africa Anti-glaucoma Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anti-glaucoma Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Anti-glaucoma Drug Introduction
11.1.4 Pfizer Revenue in Anti-glaucoma Drug Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Anti-glaucoma Drug Introduction
11.2.4 Merck Revenue in Anti-glaucoma Drug Business (2016-2021)
11.2.5 Merck Recent Development
11.3 Allergan
11.3.1 Allergan Company Details
11.3.2 Allergan Business Overview
11.3.3 Allergan Anti-glaucoma Drug Introduction
11.3.4 Allergan Revenue in Anti-glaucoma Drug Business (2016-2021)
11.3.5 Allergan Recent Development
11.4 Santen
11.4.1 Santen Company Details
11.4.2 Santen Business Overview
11.4.3 Santen Anti-glaucoma Drug Introduction
11.4.4 Santen Revenue in Anti-glaucoma Drug Business (2016-2021)
11.4.5 Santen Recent Development
11.5 Alcon
11.5.1 Alcon Company Details
11.5.2 Alcon Business Overview
11.5.3 Alcon Anti-glaucoma Drug Introduction
11.5.4 Alcon Revenue in Anti-glaucoma Drug Business (2016-2021)
11.5.5 Alcon Recent Development
11.6 Teva Pharmaceuticals
11.6.1 Teva Pharmaceuticals Company Details
11.6.2 Teva Pharmaceuticals Business Overview
11.6.3 Teva Pharmaceuticals Anti-glaucoma Drug Introduction
11.6.4 Teva Pharmaceuticals Revenue in Anti-glaucoma Drug Business (2016-2021)
11.6.5 Teva Pharmaceuticals Recent Development
11.7 Fera Pharmaceuticals
11.7.1 Fera Pharmaceuticals Company Details
11.7.2 Fera Pharmaceuticals Business Overview
11.7.3 Fera Pharmaceuticals Anti-glaucoma Drug Introduction
11.7.4 Fera Pharmaceuticals Revenue in Anti-glaucoma Drug Business (2016-2021)
11.7.5 Fera Pharmaceuticals Recent Development
11.8 Bausch & Lomb, Inc.
11.8.1 Bausch & Lomb, Inc. Company Details
11.8.2 Bausch & Lomb, Inc. Business Overview
11.8.3 Bausch & Lomb, Inc. Anti-glaucoma Drug Introduction
11.8.4 Bausch & Lomb, Inc. Revenue in Anti-glaucoma Drug Business (2016-2021)
11.8.5 Bausch & Lomb, Inc. Recent Development
11.9 Akorn, Inc.
11.9.1 Akorn, Inc. Company Details
11.9.2 Akorn, Inc. Business Overview
11.9.3 Akorn, Inc. Anti-glaucoma Drug Introduction
11.9.4 Akorn, Inc. Revenue in Anti-glaucoma Drug Business (2016-2021)
11.9.5 Akorn, Inc. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Anti-glaucoma Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Miosis Drugs
Table 3. Key Players of Beta-blocker
Table 4. Key Players of Adrenergic Agonists
Table 5. Key Players of Carbonic Anhydrase Inhibitor
Table 6. Key Players of Prostaglandin Derivative Agent
Table 7. Key Players of Penetrates
Table 8. Global Anti-glaucoma Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Anti-glaucoma Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Anti-glaucoma Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Anti-glaucoma Drug Market Share by Regions (2016-2021)
Table 12. Global Anti-glaucoma Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Anti-glaucoma Drug Market Share by Regions (2022-2027)
Table 14. Anti-glaucoma Drug Market Trends
Table 15. Anti-glaucoma Drug Market Drivers
Table 16. Anti-glaucoma Drug Market Challenges
Table 17. Anti-glaucoma Drug Market Restraints
Table 18. Global Anti-glaucoma Drug Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Anti-glaucoma Drug Market Share by Players (2016-2021)
Table 20. Global Top Anti-glaucoma Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-glaucoma Drug as of 2020)
Table 21. Ranking of Global Top Anti-glaucoma Drug Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Anti-glaucoma Drug Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Anti-glaucoma Drug Product Solution and Service
Table 25. Date of Enter into Anti-glaucoma Drug Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Anti-glaucoma Drug Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Anti-glaucoma Drug Revenue Market Share by Type (2016-2021)
Table 29. Global Anti-glaucoma Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Anti-glaucoma Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Anti-glaucoma Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Anti-glaucoma Drug Revenue Market Share by Application (2016-2021)
Table 33. Global Anti-glaucoma Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Anti-glaucoma Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Anti-glaucoma Drug Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Anti-glaucoma Drug Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Anti-glaucoma Drug Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Anti-glaucoma Drug Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Anti-glaucoma Drug Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Anti-glaucoma Drug Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Anti-glaucoma Drug Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Anti-glaucoma Drug Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Anti-glaucoma Drug Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Anti-glaucoma Drug Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Anti-glaucoma Drug Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Anti-glaucoma Drug Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Anti-glaucoma Drug Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Anti-glaucoma Drug Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Anti-glaucoma Drug Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Anti-glaucoma Drug Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Anti-glaucoma Drug Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Anti-glaucoma Drug Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Anti-glaucoma Drug Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Anti-glaucoma Drug Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Anti-glaucoma Drug Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Anti-glaucoma Drug Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Anti-glaucoma Drug Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Anti-glaucoma Drug Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Anti-glaucoma Drug Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Anti-glaucoma Drug Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Anti-glaucoma Drug Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Anti-glaucoma Drug Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Anti-glaucoma Drug Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Anti-glaucoma Drug Market Size by Country (2022-2027) & (US$ Million)
Table 65. Pfizer Company Details
Table 66. Pfizer Business Overview
Table 67. Pfizer Anti-glaucoma Drug Product
Table 68. Pfizer Revenue in Anti-glaucoma Drug Business (2016-2021) & (US$ Million)
Table 69. Pfizer Recent Development
Table 70. Merck Company Details
Table 71. Merck Business Overview
Table 72. Merck Anti-glaucoma Drug Product
Table 73. Merck Revenue in Anti-glaucoma Drug Business (2016-2021) & (US$ Million)
Table 74. Merck Recent Development
Table 75. Allergan Company Details
Table 76. Allergan Business Overview
Table 77. Allergan Anti-glaucoma Drug Product
Table 78. Allergan Revenue in Anti-glaucoma Drug Business (2016-2021) & (US$ Million)
Table 79. Allergan Recent Development
Table 80. Santen Company Details
Table 81. Santen Business Overview
Table 82. Santen Anti-glaucoma Drug Product
Table 83. Santen Revenue in Anti-glaucoma Drug Business (2016-2021) & (US$ Million)
Table 84. Santen Recent Development
Table 85. Alcon Company Details
Table 86. Alcon Business Overview
Table 87. Alcon Anti-glaucoma Drug Product
Table 88. Alcon Revenue in Anti-glaucoma Drug Business (2016-2021) & (US$ Million)
Table 89. Alcon Recent Development
Table 90. Teva Pharmaceuticals Company Details
Table 91. Teva Pharmaceuticals Business Overview
Table 92. Teva Pharmaceuticals Anti-glaucoma Drug Product
Table 93. Teva Pharmaceuticals Revenue in Anti-glaucoma Drug Business (2016-2021) & (US$ Million)
Table 94. Teva Pharmaceuticals Recent Development
Table 95. Fera Pharmaceuticals Company Details
Table 96. Fera Pharmaceuticals Business Overview
Table 97. Fera Pharmaceuticals Anti-glaucoma Drug Product
Table 98. Fera Pharmaceuticals Revenue in Anti-glaucoma Drug Business (2016-2021) & (US$ Million)
Table 99. Fera Pharmaceuticals Recent Development
Table 100. Bausch & Lomb, Inc. Company Details
Table 101. Bausch & Lomb, Inc. Business Overview
Table 102. Bausch & Lomb, Inc. Revenue in Anti-glaucoma Drug Business (2016-2021) & (US$ Million)
Table 103. Bausch & Lomb, Inc. Recent Development
Table 104. Akorn, Inc. Company Details
Table 105. Akorn, Inc. Business Overview
Table 106. Akorn, Inc. Anti-glaucoma Drug Product
Table 107. Akorn, Inc. Revenue in Anti-glaucoma Drug Business (2016-2021) & (US$ Million)
Table 108. Akorn, Inc. Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-glaucoma Drug Market Share by Type: 2020 VS 2027
Figure 2. Miosis Drugs Features
Figure 3. Beta-blocker Features
Figure 4. Adrenergic Agonists Features
Figure 5. Carbonic Anhydrase Inhibitor Features
Figure 6. Prostaglandin Derivative Agent Features
Figure 7. Penetrates Features
Figure 8. Global Anti-glaucoma Drug Market Share by Application: 2020 VS 2027
Figure 9. Hospital Pharmacy Case Studies
Figure 10. Drugstore Case Studies
Figure 11. Online Sales Case Studies
Figure 12. Anti-glaucoma Drug Report Years Considered
Figure 13. Global Anti-glaucoma Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Anti-glaucoma Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Anti-glaucoma Drug Market Share by Regions: 2020 VS 2027
Figure 16. Global Anti-glaucoma Drug Market Share by Regions (2022-2027)
Figure 17. Global Anti-glaucoma Drug Market Share by Players in 2020
Figure 18. Global Top Anti-glaucoma Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-glaucoma Drug as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Anti-glaucoma Drug Revenue in 2020
Figure 20. Global Anti-glaucoma Drug Revenue Market Share by Type (2016-2021)
Figure 21. Global Anti-glaucoma Drug Revenue Market Share by Type (2022-2027)
Figure 22. North America Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Anti-glaucoma Drug Market Share by Type (2016-2027)
Figure 24. North America Anti-glaucoma Drug Market Share by Application (2016-2027)
Figure 25. North America Anti-glaucoma Drug Market Share by Country (2016-2027)
Figure 26. United States Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Anti-glaucoma Drug Market Share by Type (2016-2027)
Figure 30. Europe Anti-glaucoma Drug Market Share by Application (2016-2027)
Figure 31. Europe Anti-glaucoma Drug Market Share by Country (2016-2027)
Figure 32. Germany Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Anti-glaucoma Drug Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Anti-glaucoma Drug Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Anti-glaucoma Drug Market Share by Region (2016-2027)
Figure 42. China Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Anti-glaucoma Drug Market Share by Type (2016-2027)
Figure 50. Latin America Anti-glaucoma Drug Market Share by Application (2016-2027)
Figure 51. Latin America Anti-glaucoma Drug Market Share by Country (2016-2027)
Figure 52. Mexico Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Anti-glaucoma Drug Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Anti-glaucoma Drug Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Anti-glaucoma Drug Market Share by Country (2016-2027)
Figure 58. Turkey Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Pfizer Revenue Growth Rate in Anti-glaucoma Drug Business (2016-2021)
Figure 62. Merck Revenue Growth Rate in Anti-glaucoma Drug Business (2016-2021)
Figure 63. Allergan Revenue Growth Rate in Anti-glaucoma Drug Business (2016-2021)
Figure 64. Santen Revenue Growth Rate in Anti-glaucoma Drug Business (2016-2021)
Figure 65. Alcon Revenue Growth Rate in Anti-glaucoma Drug Business (2016-2021)
Figure 66. Teva Pharmaceuticals Revenue Growth Rate in Anti-glaucoma Drug Business (2016-2021)
Figure 67. Fera Pharmaceuticals Revenue Growth Rate in Anti-glaucoma Drug Business (2016-2021)
Figure 68. Bausch & Lomb, Inc. Revenue Growth Rate in Anti-glaucoma Drug Business (2016-2021)
Figure 69. Akorn, Inc. Revenue Growth Rate in Anti-glaucoma Drug Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
【掲載企業】
Pfizer、Merck、Allergan、Santen、Alcon、Teva Pharmaceuticals、Fera Pharmaceuticals、Bausch & Lomb, Inc.、Akorn, Inc.